Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma. [electronic resource]
Producer: 20170214Description: e1925-e1928 p. digitalISSN:- 1536-3686
- Antibodies, Monoclonal -- adverse effects
- Antineoplastic Agents -- adverse effects
- Atrial Fibrillation -- chemically induced
- Bundle-Branch Block -- complications
- Humans
- Hypertension -- complications
- Ipilimumab
- Liver Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Skin Neoplasms -- pathology
- Stroke Volume
- Ventricular Dysfunction, Left -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.